Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Background and Purpose</h3><p>Acute kidney injury (AKI) is a common and critical illness, resulting in severe morbidity and a high mortality. There is a considerable interest in identifying novel molecular targets for management of AKI. Here, we investigated the potential role of the circadian clock components Rev‐erbα/β in regulation of ferroptosis and AKI.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Experimental Approach</h3><p>AKI model was established by treating mice with folic acid (FA). Regulatory effects of Rev‐erbα/β on AKI and ferroptosis were determined using single gene knockout (<i>Rev‐erbα</i><sup><i>‐/‐</i></sup> and <i>Rev‐erbβ</i><sup><i>‐/‐</i></sup>) mice, incomplete double knockout (icDKO, <i>Rev‐erbα</i><sup><i>+/‐</i></sup> <i>Rev‐erbβ</i><sup><i>‐/‐</i></sup>) mice, and cells with erastin‐induced ferroptosis. Targeted antagonism of Rev‐erbα/β to alleviate AKI and ferroptosis was assessed using the small‐molecule antagonist SR8278. Transcriptional gene regulation was investigated using luciferase reporter, mobility shift, and chromatin immunoprecipitation assays. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Key Results</h3><p>Loss of Rev‐erbα or Rev‐erbβ reduced the sensitivity of mice to FA‐induced AKI and eliminated the circadian time‐dependency in disease severity. This coincided with less extensive ferroptosis, a main cause of FA‐induced AKI. Moreover, icDKO mice were more resistant to FA‐induced AKI and ferroptosis as compared to single gene knockout mice. Supporting this, targeting Rev‐erbα/β by SR8278 attenuated ferroptosis to ameliorate FA‐induced AKI in mice. Mechanistically, Rev‐erbα/β promoted ferroptosis by repressing the transcription of <i>Slc7a11</i> and <i>HO‐1</i> (two ferroptosis‐inhibitory genes) via direct binding to a RORE cis‐element. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusion and Implications</h3><p>Targeted inhibition of Rev‐erbα/β limits ferroptosis to ameliorate FA‐induced AKI in mice. The findings may have implications for improved understanding of circadian clock‐controlled ferroptosis and for formulating new strategies to treat AKI.</p></section>

Involvement of REV-ERBα dysregulation and ferroptosis in aristolochic acid I-induced renal injury

Aristolochic acid induces acute kidney injury through ferroptosis

Activation of P53 Promotes Renal Injury in Acute Aristolochic Acid Nephropathy.

Targeted inhibition of Rev‐erb‐α/β limits ferroptosis to ameliorate folic acid‐induced acute kidney injury

Loss of nephric augmenter of liver regeneration facilitates acute kidney injury via ACSL4‐mediated ferroptosis

Hepatic Premalignant Alterations Triggered by Human Nephrotoxin Aristolochic Acid I in Canines

Identification of serum metabolites associated with aristolochic acid nephropathy severity and insights into the underlying mechanism

Interleukin-22 Attenuated Renal Tubular Injury in Aristolochic Acid Nephropathy via Suppressing Activation of NLRP3 Inflammasome

Evaluation of aristolochic acid Ι nephrotoxicity in mice via 1H NMR quantitative metabolomics and network pharmacology approaches

Aristolochic Acid-Induced Destruction of Organic Ion Transporters and Fatty Acid Metabolic Disorder in the Kidney of Rats

Upregulation of Mir-382 Contributes to Renal Fibrosis Secondary to Aristolochic Acid-Induced Kidney Injury Via PTEN Signaling Pathway

Dissection of Targeting Molecular Mechanisms of Aristolochic Acid-induced Nephrotoxicity via a Combined Deconvolution Strategy of Chemoproteomics and Metabolomics

Cysteinyl Leukotrienes Synthesis is Involved in Aristolochic Acid I-induced Apoptosis in Renal Proximal Tubular Epithelial Cells.

The protective role of Nrf2 against aristolochic acid-induced renal tubular epithelial cell injury

Mitochondrial Iron Overload-Mediated Inhibition of Nrf2-HO-1/GPX4 Assisted ALI-Induced Nephrotoxicity

Aristolocholic acid I promotes renal tubular epithelial fibrosis by upregulating matrix metalloproteinase-9 expression via activating the C3a/C3aR axis of macrophages

Lycopene attenuates the inflammation and apoptosis in aristolochic acid nephropathy by targeting the Nrf2 antioxidant system

Curcumin alleviates aristolochic acid nephropathy based on SIRT1/Nrf2/HO-1 signaling pathway

Understanding the Aristolochic Acid Toxicities in Rat Kidneys with Regulatory Networks.

Integration of transcriptomic, proteomic and metabolomic data to reveal the biological mechanisms of AAI injury in renal epithelial cells

Augmenter of liver regeneration knockout aggravates tubular ferroptosis and macrophage activation by regulating carnitine palmitoyltransferase‐1A‐induced lipid metabolism in diabetic nephropathy